Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$28.2M Buy
14,188
+677
+5% +$1.08M 2.13% 13
2026
Q1
$17.8M Buy
13,511
+302
+2% +$414K 1.49% 23
2025
Q4
$14.1M Buy
13,209
+328
+3% +$342K 1.16% 29
2025
Q3
$12.5M Buy
12,881
+977
+8% +$768K 1.06% 30
2025
Q2
$9.54M Buy
11,904
+1,760
+17% +$1.26M 0.86% 37
2025
Q1
$6.72M Buy
10,144
+2,852
+39% +$2.07M 0.64% 48
2024
Q4
$5.05M Buy
7,292
+1,434
+24% +$1.03M 0.48% 56
2024
Q3
$4.88M Buy
5,858
+1,811
+45% +$1.62M 0.48% 57
2024
Q2
$4.14M Buy
4,047
+3,575
+757% +$3.44M 0.43% 58
2024
Q1
$458K Buy
472
+126
+36% +$112K 0.05% 115
2023
Q4
$262K Hold
346
0.03% 126
2023
Q3
$204K Buy
+346
New +$230K 0.03% 135

Other funds holding ASML

Callahan Advisors's ASML Position: Q2 2026 in Review

Callahan Advisors increased its ASML (ASML) stake by 5% in Q2 2026, buying an estimated $1.08M and bringing the position to 14,188 shares worth $28.2M. The position accounts for 2.13% of the portfolio, ranked #13.

Callahan Advisors first reported a position in ASML in Q3 2023 and has held it in 12 quarters since. 2,496 funds tracked by Wall St. Rank hold ASML as of Q2 2026.

  • Callahan Advisors held 14,188 shares of ASML worth $28.2M as of Q2 2026.
  • Callahan Advisors bought 677 ASML shares in Q2 2026, an estimated $1.08M.
  • ASML made up 2.13% of Callahan Advisors's portfolio in Q2 2026, its #13 holding.
  • Callahan Advisors first reported a position in ASML in Q3 2023 and has held it in 12 quarters since.
  • 2,496 funds tracked by Wall St. Rank held ASML as of Q2 2026.

Based on Callahan Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.